Lonza steps up PepZin marketing campaign
to market its stomach health supplement PepZin GI to healthcare
professionals in the US and Europe.
Metagenics is to market Swiss speciality chemical firm Lonza's stomach health supplement PepZin GI to healthcare professionals in the US and Europe.
To be sold under the name Zinlori 75, the patented dietary supplement contains a chelated complex of L-carnosine and zinc.This is the second of several supply channel agreements to bring PepZin GI to Europe and North America, said Lonza.The supplement has been available in Japan for over a decade under the name Polaprezinc which is manufactured by Hamari Chemicals.
PepZin GI has been studied extensively for its ability to interact with Helicobacter pylori, support gastric health, and relieve dyspeptic symptoms. With 'drug-like' patent protection, in that the molecule itself is claimed, Lonza's marketing partners get complete exclusivity.
Dan Murray, associate director of technical development for nutrition at Lonza, said: "We are very excited to have Metagenics' pharma-calibre field representatives disseminate the evidence and IP package on PepZin GI and foster adoption within the integrative healthcare sector."
